Stocks to watch - Mistral Ventures Inc. (MILV.pk)

Mistral Ventures, Corporation. is actually a development-stage company. The company was originally involved in the purchase, exploration, growth and development of natural resource qualities. Mistral Ventures purchased the Gold Bug Project. Six mineral cell claims in British Columbia, Canada in 2006. Mistral’s focus at the time was centered on exploratory mining procedures and determining an appropriate business opportunity for acquisition. As of December 31, 2007, the Company had no interests in any mineral properties.

In October 2011, the organization acquired Nature’s Bioceuticals, Corporation. Nature’s Bioceuticals develops and acquires the rights to natural medicine formulas derived from botanicals and mineral bases that are made to treat specific medical conditions. The company provides effective natural medicines that are free of the side effects usually associated with prescription drugs.

By November 2011, Nature’s Bioceuticals reported that it has acquired the chronic kidney disease (CKD) formula. Nature’s Bioceuticals, announced it has consummated acquisition of the diabetes formula and all rights to the product.

Nature’s Bioceuticals, a wholly owned subsidiary of Mistral Ventures Inc. (MILV.pk)  announced that it has received an unexpected volume of calls from people who are interested in their products. In response,  Nature’s Bioceuticals has increased their manufacturing and rollout of a number of their products to meet anticipated increase in demand.

As a result of the anticipated demand, senior management of Nature’s Bioceuticals met with the manufacturer to discuss the rollout and the manufacturing of their products. The products that will be shipped first are the Breathing Formula, Sinus Formula, Kidney Formula and the Prostate Formula.  A few weeks thereafter the Cold & Flu Formula and Weight Loss Formula rolls out of production.

Distributing opportunities for the products are also being considered to service the global market. News stations, radio stations and periodicals are requesting interviews and further information about the company’s products for their health related segments and articles.

Nature’s Bioceuticals formulas will be either sold as prescription drugs, if applied for and approved by the FDA, or sold as dietary supplements under the Dietary Supplement Health and Education Act of 1994, also referred to as DSHEA.”

Mistral Ventures Inc. (MILV.pk) 52 week: 0.00 – 0.14  Shares: 347.45M Mkt cap: 3.86M